Skip to content
Recall Observatory FDA recall evidence

Drug product

Liothyronine Sodium Tablets, USP, 5 mcg, 100-count bottles, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc.Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Ltd. Survey No. 259/15, Dadra-396 191,(U.T. of D & NH), India. NDC 62756-589-88

D-0083-2024

October 20, 2023

Class II

Product summary

Firm
SUN PHARMACEUTICAL INDUSTRIES INC
Event
Event 93256
Status
Terminated
Classification
Class II
Quantity
7392 Bottles
Official record key
drug-enforcement:D-0083-2024

Official wording

Reason: Failed Impurities/Degradation Specifications.

Code information: Lot #: DND0058A, Exp. Date 12/2023

Distribution pattern: Nationwide within the United States

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Failed Impurities/Degradation Specifications